1-7 of 7
Etsuko Yasuda
Close
Sort by
Journal Articles

Preclinical Development of AT1412, a Patient Derived CD9 Antibody That Does Not Induce Thrombosis for Treatment of B ALL

Remko Schotte, Julien Villaudy, PhD, Greta De Jong, MD, Viviana Neviani, PhD, Wouter Pos, PhD, Sophie E Levie, Daniel M Go, Etsuko Yasuda, PhD, Esmay Frankin, Madalina Cercel, Susan E van Hal-van Veen, Dorien van de Berg, Anikó Szabó, MD, Christien Fatmawati, Martijn Kedde, PhD, Yvonne Claassen, Sjeng Horbach, PhD, Anita W Rijneveld, MD PhD, Piet Gros, prof, Hergen Spits, prof, Mette D Hazenberg, MD PhD, Hans van Eenennaam, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 41–42.
https://doi.org/10.1182/blood-2020-134088
Published: 2020
Journal Articles

AT1412, a Patient-Derived Antibody in Development for the Treatment of CD9 Positive Precursor B-Acute Lymphoblastic Leukemia

Greta De Jong, Sophie E Levie, Remko Schotte, PhD, Wouter Pos, PhD, Daniel Go, Etsuko Yasuda, Madalina Cercel, Susan E van Hal-van Veen, Esmay Frankin, Anikó Szabó, MD, Julien Villaudy, PhD, Pauline M van Helden, PhD, Hans van Eenennaam, PhD, Hergen Spits, PhD, Anita W Rijneveld, MD PhD, Mette D Hazenberg, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4461.
https://doi.org/10.1182/blood-2019-127894
Published: 2019
Journal Articles

AML-specific cytotoxic antibodies in patients with durable graft-versus-leukemia responses

Marijn A. Gillissen, Martijn Kedde, Greta de Jong, Gemma Moiset, Etsuko Yasuda, Sophie E. Levie, Arjen Q. Bakker, Yvonne B. Claassen, Koen Wagner, Martino Böhne, Paul J. Hensbergen, Dave Speijer, Pauline M. van Helden, Tim Beaumont, Hergen Spits, Mette D. Hazenberg
Journal: Blood
Blood (2018) 131 (1): 131–143.
https://doi.org/10.1182/blood-2017-02-768762
Published: 2018
Includes: Supplemental data
Journal Articles

Tumor Specific Glycosylated CD43 Is a Novel and Highly Specific Target for Acute Myeloid Leukemia and Myelodysplastic Syndrome

Marijn A. Gillissen, MD, Martijn Kedde, PhD, Greta de Jong, MD, Etsuko Yasuda, PhD, Sophie E. Levie, Arjen Q. Bakker, Marie Jose Kersten, MD PhD, Paul Hensbergen, PhD, Tim Beaumont, PhD, Pauline M. van Helden, PhD, Hergen Spits, PhD, Mette D. Hazenberg, MD PhD
Journal: Blood
Blood (2016) 128 (22): 1646.
https://doi.org/10.1182/blood.V128.22.1646.1646
Published: 2016
Journal Articles

AML Relapse after Rituximab Treatment for Graft-Versus-Host Disease: Crucial Role for B Cells in Graft-Versus-Host and Graft-Versus-Leukemia

Marijn Aletta Gillissen, MD, Sophie E. Levie, Greta de Jong, MD, Etsuko Yasuda, PhD, Arjen Q. Bakker, Pauline M. van Helden, PhD, Douglas M. Jefferson, PhD, Cynthia Huisman, MD PhD, Hergen Spits, PhD, Mette D. Hazenberg, MD PhD
Journal: Blood
Blood (2015) 126 (23): 5473.
https://doi.org/10.1182/blood.V126.23.5473.5473
Published: 2015
Journal Articles

Donor-Derived B Cells Produce Potent AML-Specific Antibodies That Recognize Novel Tumor-Specific Antigens and Mediate Graft-Versus-Leukemia Immunity

Marijn Aletta Gillissen, MD, Martijn Kedde, Etsuko Yasuda, PhD, Sophie E. Levie, Arjen Q. Bakker, Yvonne B. Claassen, Martino Bohne, Dave Speijer, PhD, Daisy I. Picavet, Jan Stap, Marinus H. J. van Oers, Tim Beaumont, PhD, Pauline M. van Helden, PhD, Hergen Spits, PhD, Mette D. Hazenberg, MD PhD
Journal: Blood
Blood (2015) 126 (23): 3146.
https://doi.org/10.1182/blood.V126.23.3146.3146
Published: 2015
Journal Articles

Unique and Potent Tumor Specific Antibodies in Graft Versus Leukemia Responses

Marijn A. Gillissen, MD, Etsuko Yasuda, PhD, Sophie Levie, Arjen Q Bakker, Martijn Kedde, Yvonne B Claassen, Cynthia Huisman, MD PhD, Hergen Spits, PhD, Tim Beaumont, PhD, Mette D. Hazenberg, MD PhD
Journal: Blood
Blood (2014) 124 (21): 3826.
https://doi.org/10.1182/blood.V124.21.3826.3826
Published: 2014